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June 2, 2004:2147–51dvantage of this simple and noninvasive method may allow
creening of a large number of patients at risk. Prospective
valuation of data may demonstrate a correlation of vascular
ysfunction in the skin microcirculation with cardiovascular
vents.
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agnetic Resonance to Assess the
ortic Valve Area in Aortic Stenosis
he study by John et al. (1) describes the results of a comparative
tudy using cardiovascular magnetic resonance (CMR) to measure
ortic valve area in patients with aortic valve stenosis. It is
mportant to emphasize the potential of this technique to perform
planimetric quantification of the stenosis. But in order to avoid
isappointing results by future applicants of that approach, it
hould be added that the technique used in this study is not
tate-of-the-art. The sequence used (flash two-dimensional cine
radient echo) uses an echo time of 4.8 ms and thus is very likely
o suffer from so-called spin-dephasing artifacts which display the
ransstenotic jet as a (gray to black) signal void. This makes it
ifficult to reliably measure the area as reported by the authors. If
thers are willing to apply CMR to measure valve area, they should
ake use of steady-state-free-precession (SSFP) sequences with
uch shorter echo times and thus more easily identifiable orifices.
he use of the standard SSFP sequence is much less susceptible to
his problem (2). In a recent study, we have shown that using this
tate-of-the-art technique, CMR yields reliable results (3). In
reparing this study, we have compared both techniques and
xperienced a limited accuracy of the technique used by John et al.
hen compared with the SSFP-based approach. catthias Friedrich, MD, FESC
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EPLY
e agree with Dr. Friedrich and his colleagues that the technique
e used in our study (fast low-angle shot [FLASH]) is not as new
s the steady-state free-precession (SSFP)-based techniques.
owever, it would also be incorrect to assume that using SSFP
echniques eliminates all potential errors with aortic valve area
easurements. Both FLASH and SSFP techniques have their own
ources of artefacts. While it is true, as Dr. Friedrich and his
olleagues pointed out, that FLASH techniques are susceptible to
ignal loss as a result of spin-dephasing effects, if the same
arameters are used for all subjects (including slice thickness, flow
ompensation gradients, echo time, repetition time flip angle), one
an be reasonably confident in making area measurements as
ointed out in our study. The SSFP techniques have less sensitivity
o the dephasing effect, but they have different sources of artefacts,
ncluding sensitivity to areas of magnetic field disturbance (calci-
cations, tissue interfaces, and so forth) and sometimes severe
rtefacts in areas of highly complex flow. As a result of these
ifferences, many use a combination of FLASH and SSFP
echniques for magnetic resonance (MR) valve assessment in
ractice.
During study data acquisition (1), both FLASH and SSFP
ased sequences were tested. We found that the amount of artefact
n the SSFP cines was often higher than in the FLASH cines,
specially in aortic valve cross sections (2). We therefore decided to
se FLASH rather than SSFP cines for planimetry of the aortic
alve in the aforementioned study.
Perhaps the overall message to readers who may be consid-
ring using MR for valve area measurements should be the
ollowing: The appearance and size of signal voids on MR
mages are highly dependent on a number of parameters of the
ulse sequence chosen. Therefore, a FLASH or SSFP sequence
t one institution or scanner cannot be immediately assumed to
e the same as another institution or scanner. It is prudent in all
ases to attempt to replicate the parameters reported in the
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June 2, 2004:2147–51iterature, but then to perform a small validation study before
dopting a new technique with confidence.
nna S. John, MD
oyal Brompton Hospital
ardiovascular MR Unit
ydney Street
ondon, SW3 6NP
nited Kingdom
-mail: a.john@rbh.nthames.nhs.uk
horsten Dill, MD
doi:10.1016/j.jacc.2004.03.011
EFERENCES
. John AS, Dill T, Brandt RR, et al. Magnetic resonance to assess the
aortic valve area in aortic stenosis: how does it compare to current
diagnostic standards? J Am Coll Cardiol 2003;42:519–26.
. John AS, Kilner PJ, Mohiaddin RH, Lorenz CH, Pennell DJ. Com-
parison of TrueFISP and FLASH in valve disease (abstr). J Cardiovasc
Magn Res 2001;3:84–5.
herapy of Recurrent Pericarditis
e read with interest the paper by Raatikka et al. (1) that gives us
useful piece of information regarding pericarditis in children.
he data are relevant, particularly regarding the good long-term
utcome, with no instance of constriction, in agreement with our
xperience in adults. We would like to comment on some
tatements regarding therapy. The authors in fact conclude that
orticosteroids, methotrexate, azathioprine, cyclosporine, and col-
hicine did not prevent recurrences. Should we conclude that no
rug is effective, so that no drug should be employed? We have
ublished case reports describing different experiences. A 14.5-
ear-old boy (2) previously treated with high-dose steroids, intra-
enous immunoglobulin, and indomethacin experienced an excel-
ent response when colchicine 1 mg was added, while slowly
apering steroids and continuing indomethacin. In another 12-
ear-old boy (3) who did not respond well to nonsteroidal
nti-inflammatory drugs (NSAIDs) and prednisone, the introduc-
ion of colchicine proved beneficial; thereafter, the patient pre-
ented with six relapses, each occurring 1 to 4 weeks after the
iscontinuation of colchicine on his own initiative. The excellent
tudy by Raatikka et al. (1), in our opinion, was not designed to
ssess the problem of therapy, with the interactions between
ifferent drugs, dosages, and combinations: we have to wait for
ore definitive studies specifically addressing therapy. Moreover,
e have to evaluate if efficacy of a drug means that it must work
fter discontinuing all the previous therapies (e.g., to stop steroids
nd NSAIDs and add de novo colchicine) or, probably more
isely, if a drug’s efficacy means that it works when added to a
revious active therapy (e.g., to add colchicine to steroids and
SAIDs).
In the meantime, even if it will be proved true that recurrent
ericarditis has a chronic course irrespective of the therapy given,
nd that the activity of the disease gradually “burns out” sponta-
eously, it remains necessary to use some drugs, the less toxic ones,
uring the acute phases. In our opinion, this is best accomplished mith a multidrug therapy including: 1) a very slow tapering of
teroids (months), similar to what is often done in many rheuma-
ologic conditions; 2) NSAIDs used at the recommended dosages;
nd 3) introduction of colchicine, if tolerated. In our experience,
his therapy greatly ameliorates the quality of life of these patients,
nd possibly may reduce the number of recurrences. We acknowl-
dge that it will be difficult to formally prove the efficacy of this
herapy in the framework of a randomized, controlled trial.
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EPLY
e appreciate the interest of Dr. Brucato and his colleagues in our
tudy on recurrent pericarditis in children and adolescents (1). We
gree that the treatment of this condition is often problematic and
rustrating. The goals of the therapy are to control the pain, to
revent tamponade, and to stop recurrences. In our series, threat-
ning tamponade was not encountered after first attacks and
ericardial effusion diminished in later relapses irrespective of the
iven therapy. Thus, the control of pain remains the main task in
herapy during a recurrence of the disease. This is possible in most
ases with nonsteroidal anti-inflammatory drugs (NSAIDs) in
ufficient doses, added with other pain killers if needed. Even
ecurrences with high C-reactive protein values usually settle down
ith such treatment within 7 to 10 days. It is tempting to use
orticosteroids as they are very effective in suppressing the pain and
n relieving the pericardial effusion. However, in our patients
teroid treatment tended to increase the number of relapses.
urther, the well-known side effects of corticosteroids are espe-
ially undesirable in growing children and adolescents. Therefore,
e would spare the corticosteroid treatment for the most severe
ases only.
Colchicine treatment for preventing relapses has raised consid-
rable expectations because of the good results published by Adler
t al. (2). Sadly, this treatment failed to prevent recurrences in all
our of our patients in whom colchicine was added to corticoste-
oid treatment. One possible reason for the contradicting results
ay lie in the different genetic characteristics of the study
